Literature DB >> 35382400

Acute renal failure in systemic sclerosis revealing Goodpasture syndrome: "All that glitters is not scleroderma renal crisis".

Renaud Felten1, Benoît Nespola2, Emmanuel Chatelus1, Laurent Arnaud1, Jacques-Eric Gottenberg1, Matthieu Canuet3, Eric Prinz4, Joëlle Goetz2, Jean Sibilia1.   

Abstract

The most common cause of acute renal failure in systemic sclerosis patients is scleroderma renal crisis but other etiologies have to be considered such as another autoimmune disease. We report the case of a 60-year-old male admitted to our hospital with a renal failure. His medical history included a diagnosis of systemic sclerosis 6 months ago. Antinuclear antibodies were positive at a titer of 1:1280 with positive anti-Scl-70 and anti-myeloperoxidase (34 U/mL) antibodies. Scleroderma renal crisis was suspected. However, antineutrophil cytoplasmic antibody-associated vasculitis could not be excluded and a renal biopsy was performed. Histopathology revealed crescentic glomerulonephritis and rupture of Bowman's capsule. Anti-glomerular basement membrane antibodies were detected in serum and the diagnosis of Goodpasture syndrome was confirmed by kidney's immunofluorescence analysis showing typical deposits. Only three other cases of systemic sclerosis associated with Goodpasture syndrome have been reported in the literature. Also, rapidly progressive glomerulonephritis with positivity of both antineutrophil cytoplasmic antibody and anti-glomerular basement membrane antibodies has been described. Several studies have suggested that antineutrophil cytoplasmic antibody positivity occurs first leading to damages of the glomerular basement membrane, to the release of alpha-3 NC1 antigen, and ultimately to anti-glomerular basement membrane antibody production. Although rare, antineutrophil cytoplasmic antibody-associated vasculitis and Goodpasture syndrome should be searched for in systemic sclerosis patients with acute renal failure.
© The Author(s) 2019.

Entities:  

Keywords:  Goodpasture syndrome; Systemic sclerosis; anti-glomerular basement membrane antibody; anti-myeloperoxidase antibody; antineutrophil cytoplasmic antibody; scleroderma renal crisis

Year:  2019        PMID: 35382400      PMCID: PMC8922589          DOI: 10.1177/2397198319838131

Source DB:  PubMed          Journal:  J Scleroderma Relat Disord        ISSN: 2397-1983


  22 in total

Review 1.  Anti-neutrophil antibody associated vasculitis in systemic sclerosis.

Authors:  Uri Arad; Alexandra Balbir-Gurman; Keren Doenyas-Barak; Mirit Amit-Vazina; Dan Caspi; Ori Elkayam
Journal:  Semin Arthritis Rheum       Date:  2011-02-01       Impact factor: 5.532

2.  Crescentic glomerulonephritis and microangiopathic haemolytic anaemia in a patient with established systemic sclerosis.

Authors:  Katrine Brakke Norheim; Sabine Leh; Lasse Gøransson
Journal:  Scand J Urol Nephrol       Date:  2011-10-13

Review 3.  Epidemiology of systemic sclerosis.

Authors:  Mandana Nikpour; Wendy M Stevens; Ariane L Herrick; Susanna M Proudman
Journal:  Best Pract Res Clin Rheumatol       Date:  2010-12       Impact factor: 4.098

4.  Asymptomatic autoantibodies associate with future anti-glomerular basement membrane disease.

Authors:  Stephen W Olson; Charles B Arbogast; Thomas P Baker; David Owshalimpur; David K Oliver; Kevin C Abbott; Christina M Yuan
Journal:  J Am Soc Nephrol       Date:  2011-08-25       Impact factor: 10.121

5.  Development of anti-glomerular basement membrane disease after remission from perinuclear ANCA-associated glomerulonephritis in a patient with HLA susceptibility.

Authors:  Kate O'Connor; David Fulcher; Richard K S Phoon
Journal:  Am J Kidney Dis       Date:  2009-09-06       Impact factor: 8.860

6.  Antibodies against linear epitopes on Goodpasture autoantigen in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Xiao-Yu Jia; Jun-Tao Yu; Shui-Yi Hu; Jian-Nan Li; Miao Wang; Chen Wang; Min Chen; Zhao Cui; Ming-Hui Zhao
Journal:  Clin Rheumatol       Date:  2017-05-26       Impact factor: 2.980

Review 7.  Goodpasture's syndrome: a clinical update.

Authors:  Antonio Greco; Maria Ida Rizzo; Armando De Virgilio; Andrea Gallo; Massimo Fusconi; Giulio Pagliuca; Salvatore Martellucci; Rosaria Turchetta; Lucia Longo; Marco De Vincentiis
Journal:  Autoimmun Rev       Date:  2014-11-15       Impact factor: 9.754

8.  Clinical features and outcome of patients with both ANCA and anti-GBM antibodies.

Authors:  Jeremy B Levy; Tarig Hammad; Anne Coulthart; Tammy Dougan; Charles D Pusey
Journal:  Kidney Int       Date:  2004-10       Impact factor: 10.612

9.  [Case of scleroderma with rapid progressive glomerulonephritis associated with both MPO-ANCA and anti-GBM antibodies].

Authors:  Tomoko Namba; Masaki Hatanaka; Atsushi Takahashi; Masanobu Takeji; Ken Takahara; Takashi Uzu; Atsushi Yamauchi
Journal:  Nihon Jinzo Gakkai Shi       Date:  2008

10.  Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients.

Authors:  Stephen P McAdoo; Anisha Tanna; Zdenka Hrušková; Lisa Holm; Maria Weiner; Nishkantha Arulkumaran; Amy Kang; Veronika Satrapová; Jeremy Levy; Sophie Ohlsson; Vladimir Tesar; Mårten Segelmark; Charles D Pusey
Journal:  Kidney Int       Date:  2017-05-12       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.